Thanks for your post CS99, I'm glad to hear that there could be a reasonable cause for the trial delay other than just the general incompetence of RVX management. I also agree there is no excuse for not communicating what the new start target might be since they have clearly missed their initial target. That would be just way to easy. 

It is astonishing that management expects the market to respond to the science when the business has no visible, solid means of support, never hits their targets and has abysmal communications.